Tumoricidal activity of antiseptics with assessment of cell viability in mice with severe combined immunodeficiency

Tumor Biology

Volumn 18, Issue 4, 1997, Pages 213-218

  Basha, G ^a   Penninckx, F ^a   Geboes, K ^a   Yap, P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cell viability; Cytotoxicity; Povidone iodine; Tumoricidal activity

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ANTIINFECTIVE AGENT; TOSYLCHLORAMIDE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RECURRENCE; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MOUSE; PRIORITY JOURNAL;

EID: 0030854979     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218034     Document Type: Article

References (29)

1. Ryall C: Cancer infection and cancer recurrence, Lancet 1907;ii: 1311-1316.
2. Ryall C: The technique of cancer operations with relation to the danger of cancer infection, Br Med J 1908;ii: 1005-1008.
3. Gordon-Watson C: Origin and spread of cancer of the rectum in relation to surgical treatment, lancet 1938;i:239-245.
4. Morgan CN, Lloyd-Davics OV: Restorative resection of the rectum, Proc R Soc Med 1950;43:701-710.
5. Waltzer AK, Altemeier WA: Mechanisms and prevention of recurrence of carcinoma at the suture line, Surg Forum 1965;16:118-120.
6. Phillips RKS, Hittingcr R, Blcsov-sky L, Fry JS, Fielding LP: Local recurrence following ‘curative’ surgery for large bowel cancer: I, The overall picture, Br J Surg 1984;71: 12-16.
7. Umpleby HC, Fermor B, Symes MO, Williamson RCN: Viability of exfoliated colorectal carcinoma cells, Br J Surg 1984;71:659-663.
8. Vink M: Local recurrence of cancer in large bowel: The role of implantation metastases and bowel disinfection, Br J Surg 1954;41:431-433.
9. Cohn I Jr, Atik M: The influence of antibiotics on the spread of tumours of the colon, Ann Surg 1960; 151: 917-927.
10. Umpleby HC, Williamson RCN: The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma, Ann R Coll Surg Engl 1984;66:192-194.
11. Skipper D, Cooper AJ, Marston JE, Taylor I: Exfoliated cells and in vitro growth in colorectal cancer, Br J Surg 1987;74:1049-1052.
12. McGregor JR, Galloway DJ, McCulloch P, George WD: Anastomotic suture materials and implantation metastasis: An experimental study, Br J Surg 1989;76:331-334.
13. Symes MO, Fermor B, Umpleby HC, Tribe CR, Williamson RCN: Cells exfoliated from colorectal cancers can proliferate in immune deprived mice, Br J Cancer 1984,50: 423-425.
14. Fermor B, Umpleby HC, Lever JV, Symes MO, Williamson RCN: Proliferative and metastatic potential of exfoliated colorectal cancer cells, J Natl Cancer Inst 1986;76:347-349.
15. McDonald GE, Gines SM, Cole WH: Wound irrigation in cancer surgery, Arch Surg 1960;80:920-927.
16. Gubareff N, Suntzef TV: Preliminary report on application of iodine in prevention of surgical dissemination of viable malignant cells, J Surg Res 1962;2:144-145.
17. McKibbin B, Gazet JC, Hoppe E: Chemical irrigation of wounds inoculated with cancer cells, Arch Surg 1963;87:877-880.
18. Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O’Dwyer PJ: Efficacy of tumoricidal agents in vitro and in vivo, Br J Surg 1995;82: 1050-1052.
19. Basha G, Yap P, Penninckx F: Comparative study of classical, colorimetric and immunologic staining methods for the assessment of tumour cell viability, Tumor Biology 1996;17:354-361.
20. Fogh J, Fogh JM, Orfeo TH: One hundred and twenty-seven cultured human tumour cell lines producing tumours in nude mice, J Natl Cancer Inst 1977;59:221-226.
21. Bosnia GC, Custer RP, Bosma MJ: A severe combined immunodeficiency mutation in the mouse, Nature 1983;301:527-530.
22. Tennant JR: Evaluation of the trypan blue technique for determination of the cell viability, Transplantation 1964;2:685-694.
23. Fukurawa T, Watanabe M, Kubota T, Kitajirra M: Paradoxal enhancement of tumour growth in mice with severe combined immunodeficiency which produce a human immunoglobulin G reactive against tumour cells, Jpn J Cancer Res 1994:85:72- 79.
24. Inohara H, Matsunaga T, Nomura T: Growth and metastasis of fresh human benign and malignant tumours in the head and neck regions transplanted into SCID mice, Carcinogenesis 1992;13:845-849.
25. Von Kalle C, Wolf J, Becker A, Sckaer A, Munck M, Engcrt A, Kapp U, Fonatsch C, Komitowski D, Feaux de Lacroix W, Diehl V: Growth of Hodgkin cell lines in severely combined immunodeficient mice, Int J Cancer 1992,52:887-891.
26. Fukurawa T, Kubota T, Watanabe M, Nishibori H, Kuo T, Saikawa Y, Kase S, Tanino H, Teramoto T, Ishi-biki K, Kitajima M: A suitable model for experimental liver metastasis of human colon cancer xenografts using mice with severe combined immunodeficiency, J Surg Oncol 1993;52:64-67.
27. Huang Y, Richardson JA, Tong AW, Zhang BQ, Stone MJ, Vitetta ES: Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease, Cancer Res 1993;53:1392-1396.
28. Bellamy WT, Odeleye A, Finley P, Huizenga B, Dalton WS, Weinstein RS, Hcrsch EM, Grogan TM: An in vivo model of human multidrug-resistant multiple myeloma in SCID mice, Am J Pathol 1993; 142:691 - 698.
29. Reddy S, Piccione D, Takita H, Bankcrt RB: Human lung tumour growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency, Cancer Res 1987:47:2456-2460.